Related Research Articles
Gram-negative bacteria are bacteria that do not retain the crystal violet stain used in the Gram staining method of bacterial differentiation. They are characterized by their cell envelopes, which are composed of a thin peptidoglycan cell wall sandwiched between an inner cytoplasmic cell membrane and a bacterial outer membrane.
Escherichia coli, also known as E. coli, is a Gram-negative, facultative anaerobic, rod-shaped, coliform bacterium of the genus Escherichia that is commonly found in the lower intestine of warm-blooded organisms (endotherms). Most E. coli strains are harmless, but some serotypes (EPEC, ETEC etc.) can cause serious food poisoning in their hosts, and are occasionally responsible for food contamination incidents that prompt product recalls. The harmless strains are part of the normal microbiota of the gut, and can benefit their hosts by producing vitamin K2, (which helps blood to clot) and preventing colonisation of the intestine with pathogenic bacteria, having a mutualistic relationship. E. coli is expelled into the environment within fecal matter. The bacterium grows massively in fresh fecal matter under aerobic conditions for 3 days, but its numbers decline slowly afterwards.
Polymyxins are antibiotics. Polymyxins B and E are used in the treatment of Gram-negative bacterial infections. They work mostly by breaking up the bacterial cell membrane. They are part of a broader class of molecules called nonribosomal peptides.
Stanley Falkow was an American microbiologist and a professor of microbiology and immunology at Stanford University School of Medicine. He discovered molecular mechanisms of infectious diseases, like antibiotic resistance and sounded the alarm for antibiotic-resistant bacteria. He championed the benefits of microorganisms. He formulated molecular Koch's postulates, which have guided the study of the microbial determinants of infectious diseases since the late 1980s.
Lysogeny broth (LB) is a nutritionally rich medium primarily used for the growth of bacteria. Its creator, Giuseppe Bertani, intended LB to stand for lysogeny broth, but LB has also come to colloquially mean Luria broth, Lennox broth, life broth or Luria–Bertani medium. The formula of the LB medium was published in 1951 in the first paper of Bertani on lysogeny. In this article he described the modified single-burst experiment and the isolation of the phages P1, P2, and P3. He had developed the LB medium to optimize Shigella growth and plaque formation.
Thomas J. Silhavy is the Warner-Lambert Parke-Davis Professor of molecular biology at Princeton University. Silhavy is a bacterial geneticist who has made fundamental contributions to several different research fields. He is best known for his work on protein secretion, membrane biogenesis, and signal transduction. Using Escherichia coli as a model system, his lab was the first to isolate signal sequence mutations, identify a component of cellular protein secretion machinery, discover an integral membrane component of the outer membrane assembly machinery, and to identify and characterize a two-component regulatory system. Current work in his lab is focused on the mechanisms of outer membrane biogenesis and the regulatory systems that sense and respond to envelope stress and trigger the developmental pathway that allows cells to survive starvation. He is the author of more than 200 research articles and three books.
Walter Dobrogosz is a Professor Emeritus of North Carolina State University, best known for his discovery and further research on the probiotic bacterium Lactobacillus reuteri.
DNA adenine methylase, (Dam methylase) is an enzyme that adds a methyl group to the adenine of the sequence 5'-GATC-3' in newly synthesized DNA. Immediately after DNA synthesis, the daughter strand remains unmethylated for a short time. It is an orphan methyltransferase that is not part of a restriction-modification system and regulates gene expression. This enzyme catalyses the following chemical reaction
The Hfq protein encoded by the hfq gene was discovered in 1968 as an Escherichia coli host factor that was essential for replication of the bacteriophage Qβ. It is now clear that Hfq is an abundant bacterial RNA binding protein which has many important physiological roles that are usually mediated by interacting with Hfq binding sRNA.
Roberto Kolter is Professor of Microbiology, Emeritus at Harvard Medical School, an author, and past president of the American Society for Microbiology. Kolter has been a professor at Harvard Medical School since 1983 and was Co-director of Harvard's Microbial Sciences Initiative from 2003-2018. During the 35-year term of the Kolter laboratory from 1983 to 2018, more than 130 graduate student and postdoctoral trainees explored an eclectic mix of topics gravitating around the study of microbes. Kolter is a fellow of the American Association for the Advancement of Science and of the American Academy of Microbiology.
Bacterial small RNAs (sRNA) are small RNAs produced by bacteria; they are 50- to 500-nucleotide non-coding RNA molecules, highly structured and containing several stem-loops. Numerous sRNAs have been identified using both computational analysis and laboratory-based techniques such as Northern blotting, microarrays and RNA-Seq in a number of bacterial species including Escherichia coli, the model pathogen Salmonella, the nitrogen-fixing alphaproteobacterium Sinorhizobium meliloti, marine cyanobacteria, Francisella tularensis, Streptococcus pyogenes, the pathogen Staphylococcus aureus, and the plant pathogen Xanthomonas oryzae pathovar oryzae. Bacterial sRNAs affect how genes are expressed within bacterial cells via interaction with mRNA or protein, and thus can affect a variety of bacterial functions like metabolism, virulence, environmental stress response, and structure.
John Roger Roth is an American geneticist, bacterial physiologist, and evolutionist. He is a Distinguished Professor of Biological Sciences at the University of California, Davis.
Jayaraman Gowrishankar is an Indian medical microbiologist. Gowrishankar received his M.B.B.S. degree from the Christian Medical College, Vellore. He holds Doctor of philosophy in bacterial genetics from the University of Melbourne.
Bacterial effectors are proteins secreted by pathogenic bacteria into the cells of their host, usually using a type 3 secretion system (TTSS/T3SS), a type 4 secretion system (TFSS/T4SS) or a Type VI secretion system (T6SS). Some bacteria inject only a few effectors into their host’s cells while others may inject dozens or even hundreds. Effector proteins may have many different activities, but usually help the pathogen to invade host tissue, suppress its immune system, or otherwise help the pathogen to survive. Effector proteins are usually critical for virulence. For instance, in the causative agent of plague, the loss of the T3SS is sufficient to render the bacteria completely avirulent, even when they are directly introduced into the bloodstream. Gram negative microbes are also suspected to deploy bacterial outer membrane vesicles to translocate effector proteins and virulence factors via a membrane vesicle trafficking secretory pathway, in order to modify their environment or attack/invade target cells, for example, at the host-pathogen interface.
B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.
Frederick C. Neidhardt (1931-2016) was an American microbiologist who was on the faculty at Purdue University and the University of Michigan. He is known for his work on the physiology and biochemistry of bacterial growth and for early work in bacterial proteomics.
Maxime Simon Schwartz, born in June 1940 in Blois (Loir-et-Cher), is a French molecular biologist who has been a research director at the CNRS, a professor at the Pasteur Institute and Director General of the Pasteur Institute. He is a correspondant of the French Academy of sciences.
In bacteriology, minicells are bacterial cells that are smaller than usual. The first minicells reported were from a strain of Escherichia coli that had a mutation in the Min System that lead to mis-localization of the septum during cell division and the production of cells of random sizes.
Abraham Eisenstark was an American professor of microbiology. He was a Guggenheim Fellow for the academic year 1958–1959.
Armen Trchounian was an Armenian biophysicist. D.Sc. in Biological sciences (1990) and professor (2002), Corresponding Member of NAS RA (2006) and Head of the Department of Biochemistry, Microbiology, and Biotechnology of Yerevan State University (2016–2020).
References
- 1 2 3 4 "Adjunct Faculty - Moselio Schaechter". San Diego State University. Retrieved 1 November 2016.
- ↑ Schaechter, Moselio. "Elio's Memoirs" . Retrieved 1 November 2016.
- ↑ Schaechter, Moselio, ed. (2009). Encyclopedia of microbiology (3rd ed.). [S.l.]: Elsevier. ISBN 978-0-12-373944-5.
- ↑ Schaechter, Moselio, ed. (2012). Eukaryotic microbes. Amsterdam: Elsevier/Academic Press. ISBN 978-0-12-383876-6.
- ↑ "Moselio Schaechter Distinguished Service Award". American Society for Microbiology. Retrieved 1 November 2016.
- ↑ "About Small Things Considered". Small Things Considered. Retrieved 1 November 2016.
- ↑ "This Week in Microbiology". Microbe World. Archived from the original on 1 November 2016. Retrieved 1 November 2016.
- ↑ Schaechter, Moselio (21 April 2015). "A brief history of bacterial growth physiology". Frontiers in Microbiology. 6: 289. doi: 10.3389/fmicb.2015.00289 . PMC 4404942 . PMID 25954250.
- ↑ Schaechter, M.; The View From Here Group (1 March 2001). "Escherichia coli and Salmonella 2000: the View From Here". Microbiology and Molecular Biology Reviews. 65 (1): 119–130. doi:10.1128/MMBR.65.1.119-130.2001. PMC 99021 . PMID 11238988.
- ↑ Ogden, GB; Pratt, MJ; Schaechter, M (1 July 1988). "The replicative origin of the E. coli chromosome binds to cell membranes only when hemimethylated". Cell. 54 (1): 127–35. doi:10.1016/0092-8674(88)90186-9. PMID 2838178. S2CID 37707837.
- ↑ Schaechter, Elio (1997). In the company of mushrooms : a biologist's tale (1st paperback ed.). Cambridge, Mass.: Harvard University Press. ISBN 978-0674445543.
| General | |
|---|---|
| National libraries | |
